![]() |
市场调查报告书
商品编码
1559481
打鼾防止设备:市场洞察·竞争环境·市场预测 (~2030年)Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
防打鼾设备市场规模将从2023年的16.1亿美元成长到2030年的25.8亿美元,在2024年至2030年的预测期内复合年增长率为7.02%。
由于睡眠障碍和忧郁症、慢性阻塞性肺病和肥胖等危险因子的盛行率不断增加,以及强调睡眠重要性的睡眠意识活动和计划的激增,预计从2024 年到2030 年,防打鼾设备市场将出现成长由于在预测期内技术先进的睡眠设备的推出预计会增加,预计睡眠量将显着增长。
根据 DelveInsight 的分析,预计 2021 年七个主要国家诊断出的阻塞性睡眠呼吸中止症 (OSA) 病例总数为 24,165,544 例。根据世界卫生组织 (WHO) 2021 年报告,2019 年全球约有 2.8 亿人患有忧郁症。几项研究报告称,患有忧郁症的人可能在晚上难以入睡和保持睡眠状态,或者可能在白天过度嗜睡。
根据全球疾病负担研究的数据,2019年全球报告的慢性阻塞性肺病病例数为2.123亿。慢性阻塞性肺病会导致持续且进行性的呼吸道症状,例如呼吸困难、咳嗽和产生痰。因此,慢性阻塞性肺病患者也会出现睡眠呼吸暂停,导致一种称为 "重迭综合症" 的疾病。
肥胖等严重疾病也会加剧各种睡眠障碍的症状并破坏个人的睡眠品质。对于肥胖的人来说,脂肪会在上呼吸道中堆积,使上呼吸道变窄,并减少这些区域的肌肉活动,导致缺氧和呼吸中止发作,从而导致睡眠呼吸中止症等睡眠障碍。这些因素的相互作用预计将在预测期内提振市场。
本报告提供全球打鼾防止设备的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and its risk factors such as depression, COPD, obesity, surging number of sleep awareness campaigns and programs, among others across the globe.
The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030. The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.
Anti Snoring Devices Market Dynamics:
As per DelveInsight analysis, in 2021, the estimated total diagnosed cases of obstructive sleep apnea (OSA) in the 7MM region was 24,165,544. According to World Health Organization 2021, worldwide around 280 million people were suffering from depression in 2019. Several research studies have concluded that individuals going through depression may find it difficult to fall and stay asleep during the night or experience periods of excessive daytime sleepiness.
As per data from the Global Burden of Disease Study, there were 212.3 million prevalent cases of COPD reported in 2019 globally. COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough, and phlegm production. Thus, people with COPD will also have sleep apnea, the combination leading to a condition called "overlap syndrome".
Severe conditions such as obesity also aggravate the symptoms of various sleep disorders that may disrupt the sleep quality of an individual. In obese people, fat deposits in the upper respiratory tract narrow the airway; decreasing muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep discrepancies such as sleep apnea. Thus, the interplay of all the above-mentioned factors is expected to boost the market for anti snoring devices during the forecasted period.
However, the various complications associated with anti snoring devices, the unreliable efficacy, and the lack of proven studies for the use of anti snoring devices, among others may act as restraining factors for the overall growth of the anti snoring devices during the forecast period.
Anti Snoring Devices Market Segment Analysis:
Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the device type segment of the anti-snoring devices market, the Continuous Positive Airway Pressure (CPAP) Devices category is projected to hold a considerable market share in 2023. The various advantages associated with CPAP therapy and the various product development activities such as launches are expected to drive the market demand for this category during the forecast period.
CPAP ventilators deliver a constant pressure of air, both while inhaling and exhaling, due to which CPAP ventilators form one of the most common forms of treatment procedures for the management of mild obstructive sleep apnea. CPAP includes automatic PAP therapy (APAP) as well, which uses an automatically adjusting positive airway pressure machine to treat obstructive sleep apnea. APAP devices may also be referred to as auto-titrating CPAP or auto-CPAP machines.
Moreover, in February 2024, ResMed announced the launch of its AirFit F40 ultra-compact, full-face mask indicated for sleep apnea. The device offers the comfort of smaller masks without sacrificing performance, thus helping with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.
Thus, all the above-mentioned factors are expected to boost the market for the CPAP category, thereby escalating the overall market for anti snoring devices during the forecast period.
North America is expected to dominate the overall anti snoring devices market:
North America is expected to account for the highest proportion of the Anti Snoring Devices market in 2023, out of all regions North America is expected to dominate the overall Anti Snoring Devices market during the forecast period.
The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period. As per data by the Centers for Disease Control and Prevention 2022, around 17.8% of adults had trouble staying asleep owing to various reasons such as sleep apnea in the US in 2020.
Further, the American Sleep Apnea Association 2023 stated that nearly 84 million people which means one in three American adults do not get the required uninterrupted sleep due to snoring and breathing difficulties regularly.
The presence of organizations such as the National Sleep Foundation (NSF), independently creates Sleep Awareness Week each year as the flagship campaign for sleep health awareness and education in the US.
NSF recognizes evidence and consensus-based best practices for sleep health throughout Sleep Awareness Week, including professional advice and useful pointers to assist people in getting the necessary quantity and quality of sleep.
Thus, the interplay of all the aforementioned factors is likely to fuel the regional market growth and demand for anti snoring devices in North America during the forecasted period from 2024 to 2030.
Anti Snoring Devices Market Key Players:
Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.
Recent Developmental Activities in the Anti Snoring Devices Market:
Key Takeaways from the Anti Snoring Devices Market Report Study:
Target audience who can be benefited from this Anti Snoring Devices Market Report Study:
Frequently Asked Questions for the Anti Snoring Devices Market:
Anti snoring devices are devices that help keep the nasal passages open and relieve snoring. Nasal snoring can be relieved with the use of nasal anti-snoring devices such as nasal strips, and nasal dilators, among others that keep the nostrils open during sleep.
The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030.
The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, the surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.
Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.
North America is expected to account for the highest proportion in the Anti Snoring Devices market in 2023, out of all regions. The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period.